At5g63930 Antibody

What is At5g63930 and why is it important in plant research?

At5g63930, also known as PSYR3, is a leucine-rich repeat receptor-like kinase (LRR-RLK) in Arabidopsis thaliana that plays a significant role in plant immunity. Recent screening studies have identified it as a key component in Pattern-Triggered Immunity (PTI) signaling pathways. The kinase domain of At5g63930 has been shown to facilitate robust signal transduction, particularly in the PR1-dependent pathway, conferring heightened resistance against bacterial pathogens such as Pseudomonas syringae pv. tomato DC3000 . Understanding this protein is crucial because it represents one of the molecular mechanisms by which plants detect and respond to pathogen invasion, making it a valuable target for agricultural research aiming to enhance crop resistance.

What are the structural characteristics of the At5g63930 protein that antibodies typically target?

At5g63930 contains distinct domains typical of LRR-RLKs, including an extracellular leucine-rich repeat domain, a transmembrane region, and an intracellular kinase domain. Antibodies for research purposes most commonly target either the highly conserved kinase domain or unique epitopes in the more variable extracellular region. The kinase domain of At5g63930 contains several conserved motifs that are characteristic of immune-related RLKs, which were identified through comprehensive sequence analysis across multiple plant species . When developing or selecting antibodies, researchers should consider whether they need to detect the native membrane-bound protein, denatured protein in Western blots, or specific phosphorylated states that indicate activation status.

How does At5g63930 function in the context of plant immune responses?

At5g63930 (PSYR3) functions as a critical component of the plant immune signaling network. When its kinase domain is experimentally fused with the extracellular domain of FLS2 (FLAGELLIN SENSING 2), it demonstrates the ability to transduce defense signals and activate downstream immunity pathways. Research has shown that At5g63930's kinase domain can effectively trigger callose deposition, induce expression of defense marker genes such as FRK1, PR1, and WRKY33, and enhance resistance against bacterial pathogens . Notably, At5g63930 appears to facilitate particularly robust signal transduction in the PR1-dependent pathway, suggesting it may play a specialized role in salicylic acid-mediated defense responses. The protein likely participates in phosphorylation cascades that ultimately lead to transcriptional reprogramming during immune responses.

What criteria should be used when selecting an antibody against At5g63930 for research?

When selecting an antibody against At5g63930, researchers should consider several critical factors. First, determine your experimental application (Western blot, immunoprecipitation, immunofluorescence, etc.) as antibodies perform differently across techniques. Second, evaluate antibody specificity through documented cross-reactivity tests with related LRR-RLKs, particularly those with similar kinase domains. Third, consider the immunogen used to generate the antibody – those raised against unique regions of At5g63930 will provide greater specificity than those targeting conserved kinase motifs. Fourth, examine validation data in publications where similar experimental conditions were used. For plant immune response studies, prioritize antibodies validated in PTI signaling contexts . Finally, consider the clonality – monoclonal antibodies offer consistency across experiments but may be sensitive to epitope changes, while polyclonal antibodies provide robust detection but with potential batch variation.

How can I validate the specificity of an At5g63930 antibody before using it in my experiments?

Validating antibody specificity for At5g63930 requires a multi-faceted approach. Start with a Western blot using wild-type Arabidopsis tissue alongside knockout or knockdown lines for At5g63930 – a specific antibody should show reduced or absent signal in mutant lines. If knockout lines are unavailable, use tissues from plants with confirmed differential expression of At5g63930, such as pathogen-challenged versus control plants. Performing immunoprecipitation followed by mass spectrometry can confirm the antibody captures the intended target. Additionally, transiently express tagged versions of At5g63930 in protoplasts using methods similar to those described in recent screening studies , then test whether the antibody recognizes the overexpressed protein. Cross-reactivity testing against closely related RLKs, particularly those with similar kinase domains identified in recent bioinformatic analyses , is essential to confirm specificity within this large protein family.

What is the optimal protocol for immunoprecipitation of At5g63930 from plant tissues?

For successful immunoprecipitation of At5g63930, begin with 1-2g of Arabidopsis tissue (preferably leaves showing active immune responses). Grind tissue in liquid nitrogen and extract proteins using a mild lysis buffer (50mM Tris-HCl pH 7.5, 150mM NaCl, 1% Triton X-100, 0.5% sodium deoxycholate, with freshly added protease inhibitors, phosphatase inhibitors, and 1mM DTT). When working with this membrane-bound receptor-like kinase, the detergent composition is critical – insufficient detergent leads to poor solubilization, while excessive amounts may disrupt protein-protein interactions. Pre-clear the lysate with protein A/G beads for 1 hour at 4°C, then incubate with At5g63930 antibody (5-10μg) overnight at 4°C with gentle rotation. Add fresh protein A/G beads and incubate for 3-4 hours, then wash extensively (at least 4 times) with washing buffer (similar to lysis buffer but with reduced detergent concentration). For co-immunoprecipitation studies investigating interaction partners in immune signaling , consider using milder wash conditions to preserve weaker interactions. Elute proteins by boiling in SDS sample buffer or using a gentler acidic glycine buffer if maintaining native structure is important.

How should At5g63930 antibodies be used to study its subcellular localization during immune responses?

To study At5g63930 subcellular localization during immune responses, immunofluorescence microscopy requires careful sample preparation to preserve membrane structures. Fix Arabidopsis seedlings or leaf sections in 4% paraformaldehyde in PBS for 30 minutes, followed by gentle cell wall digestion using a mixture of cellulase (1%) and macerozyme (0.5%) for 15 minutes. Permeabilize with 0.1% Triton X-100 for 15 minutes, then block with 2% BSA for 1 hour. Incubate with primary At5g63930 antibody (1:100-1:500 dilution depending on antibody quality) overnight at 4°C, followed by fluorophore-conjugated secondary antibody (1:500) for 2 hours at room temperature. For co-localization studies, include markers for plasma membrane, endosomes, or other cellular compartments. When tracking dynamic changes during immune responses, perform time-course experiments after elicitor treatment (e.g., flg22 at 1μM) similar to the methods used in recent studies . Confocal microscopy with z-stack imaging will provide comprehensive localization data. To validate immunofluorescence results, complement with subcellular fractionation followed by Western blotting, as well as transient expression of fluorescently-tagged At5g63930 constructs.

What methods can be used to study At5g63930 phosphorylation states using phospho-specific antibodies?

Studying At5g63930 phosphorylation requires tailored approaches for this plant receptor-like kinase. First, identify potential phosphorylation sites through in silico prediction tools and align with phosphorylation patterns of related RLKs with known immune functions. Generate or procure phospho-specific antibodies targeting these sites. When extracting proteins, use a modified extraction buffer containing strong phosphatase inhibitors (50mM NaF, 10mM Na3VO4, 10mM β-glycerophosphate, and 5mM sodium pyrophosphate). For Western blot analysis, run parallel samples probed with phospho-specific and total At5g63930 antibodies to normalize signals. To confirm specificity, treat half your sample with lambda phosphatase before immunoblotting – the phospho-specific signal should disappear. For temporal studies of phosphorylation dynamics during immune activation, collect samples at multiple timepoints (0, 5, 15, 30, 60 minutes) after treatment with PTI elicitors like flg22 (1μM), similar to protocols used in recent studies . Phosphoproteomics approaches combining immunoprecipitation with mass spectrometry can provide comprehensive mapping of multiple phosphorylation sites and identify previously unknown regulatory modifications.

How can At5g63930 antibodies be used to investigate protein-protein interactions within the immune signaling complex?

To investigate protein-protein interactions involving At5g63930 in immune signaling complexes, researchers should employ a multi-method approach. Co-immunoprecipitation using At5g63930 antibodies is the foundation – extract proteins from Arabidopsis tissues treated with immune elicitors (such as flg22) using a gentle lysis buffer that preserves protein-protein interactions. After immunoprecipitation with the At5g63930 antibody, analyze co-precipitated proteins by mass spectrometry to identify novel interaction partners. For verifying specific interactions, perform reciprocal co-IPs with antibodies against suspected partners. Proximity ligation assays (PLA) provide powerful visual confirmation of protein interactions in situ – this technique combines primary antibodies against At5g63930 and potential interacting proteins with oligonucleotide-linked secondary antibodies that generate fluorescent signals only when proteins are within 40nm of each other. For dynamic interaction studies during immune signaling, perform time-course experiments after elicitor treatment and analyze samples using bimolecular fluorescence complementation (BiFC) or Förster resonance energy transfer (FRET) with appropriate fusion constructs. Recent studies have demonstrated that certain RLKs interact with similar downstream components despite diverse upstream receptors , suggesting potential shared signaling modules worth investigating.

What methods can resolve contradictory results when analyzing At5g63930 expression patterns with antibodies versus transcriptomic data?

Resolving contradictions between antibody-detected protein levels and transcriptomic data for At5g63930 requires systematic troubleshooting and complementary approaches. First, verify antibody specificity through knockout/knockdown controls and recombinant protein standards. Second, examine time-course discrepancies – protein abundance often lags behind transcript levels, and At5g63930's involvement in immune responses may follow specific temporal dynamics . Third, investigate post-transcriptional regulation – analyze polysome-associated mRNA to determine translation efficiency. Fourth, assess protein stability through cycloheximide chase assays to measure At5g63930 half-life, which may explain accumulation despite lower transcript levels. Fifth, examine tissue-specific or subcellular compartment-specific expression patterns that might be masked in whole-tissue analyses. Complement immunoblotting with quantitative mass spectrometry using methods like selected reaction monitoring (SRM) for absolute quantification. Finally, consider the possibility of antibody cross-reactivity with related RLKs despite validation efforts, particularly given the conserved motifs identified in kinase domains of immune-related RLKs . Present both datasets in publications with appropriate discussion of the limitations and complementary nature of each approach.

How can I design experiments to study the impact of At5g63930 phosphorylation on downstream signaling using phospho-specific antibodies?

To study how At5g63930 phosphorylation affects downstream signaling, design a comprehensive experimental workflow beginning with phosphosite mapping. Use phosphoproteomics to identify key regulatory phosphorylation sites in At5g63930's kinase domain, focusing on conserved motifs identified in immune-active RLKs . Generate phospho-specific antibodies against these sites and validate using phosphatase treatments and phospho-mimetic mutants. For functional studies, create transgenic Arabidopsis lines expressing phospho-null (Ser/Thr→Ala) and phospho-mimetic (Ser/Thr→Asp/Glu) At5g63930 variants in the at5g63930 mutant background. Compare immune responses across these lines by measuring:

Perform time-course analyses following flg22 treatment (1μM) using phospho-specific antibodies to track phosphorylation dynamics, correlating with activation of downstream MAPK cascades and defense gene expression. Use co-immunoprecipitation with phospho-specific antibodies to identify phosphorylation-dependent interaction partners. Finally, employ pharmacological inhibitors of specific kinases and phosphatases to manipulate At5g63930 phosphorylation status and observe effects on PTI signaling output, similar to methods used in recent studies .

What approaches can resolve weak or inconsistent At5g63930 antibody signals in Western blots?

Weak or inconsistent At5g63930 antibody signals in Western blots can be systematically addressed through optimization of multiple parameters. First, improve protein extraction by using specialized membrane protein extraction buffers containing 1% SDS or 6M urea to fully solubilize this transmembrane receptor-like kinase. Second, adjust sample loading – At5g63930 may be low-abundance, so increasing total protein load (50-100μg) may be necessary. Third, optimize blotting conditions – extend transfer time for high-molecular-weight proteins and use PVDF membranes with 0.2μm pore size for better protein retention. Fourth, enhance antibody binding by increasing primary antibody concentration (1:500 to 1:100) and extending incubation time to overnight at 4°C. Fifth, improve detection sensitivity using amplification systems like biotin-streptavidin or tyramide signal amplification. Sixth, consider protein enrichment through immunoprecipitation prior to Western blotting. Additionally, At5g63930 expression may be strongly induced following immune stimulation , so compare samples from untreated and elicitor-treated plants. Finally, verify antibody functionality using positive control samples from Arabidopsis protoplasts overexpressing At5g63930 constructs similar to those described in recent screening studies .

How should researchers analyze quantitative differences in At5g63930 expression or modification across experimental conditions?

For rigorous quantitative analysis of At5g63930 expression or modification across experimental conditions, researchers should implement a comprehensive analytical framework. Begin with appropriate experimental design including biological replicates (minimum n=3) and technical replicates to account for variability. For immunoblot-based quantification, use internal loading controls (anti-actin or anti-tubulin) and include recombinant protein standards at known concentrations to establish a standard curve for absolute quantification. Densitometry analysis should be performed using software that can correct for background and signal saturation. For more precise quantification, consider ELISA-based approaches or quantitative mass spectrometry using isotope-labeled peptide standards. When analyzing phosphorylation changes, always normalize phospho-specific antibody signals to total At5g63930 protein levels. Statistical analysis should include appropriate tests (ANOVA with post-hoc tests for multiple conditions) and presentation of effect sizes alongside p-values. For time-course experiments following immune elicitation similar to those described in recent studies , use area-under-curve analyses or mathematical modeling to capture the dynamics of protein expression or modification. Clearly report all normalization methods, transformation of data, and statistical approaches in publications to ensure reproducibility.

What experimental controls are essential when using At5g63930 antibodies in different applications?

Essential experimental controls for At5g63930 antibody applications vary by technique but must comprehensively address specificity and reliability concerns. For Western blotting, include: (1) Knockout/knockdown samples (at5g63930 mutant) as negative controls; (2) Recombinant At5g63930 protein or overexpression samples as positive controls; (3) Pre-adsorption controls where antibody is pre-incubated with immunizing peptide; (4) Secondary-only controls to identify non-specific binding. For immunoprecipitation, additional controls include: (1) IgG-matched control antibodies to identify non-specific pull-downs; (2) Input samples to verify target presence; (3) Validation of interacting partners through reverse immunoprecipitation. For immunofluorescence: (1) Peptide competition controls; (2) Parallel staining in knockout tissues; (3) Co-localization with known compartment markers to confirm expected subcellular distribution. When studying immune responses, include time-matched mock treatments alongside elicitor treatments to distinguish constitutive from induced changes. For phospho-specific antibody applications, lambda phosphatase-treated samples are essential negative controls. Finally, when comparing immune responses across different receptor-like kinases as described in recent screening studies , include multiple related RLKs to establish specificity within this protein family. Document all control results transparently in publications, even when negative.

How might At5g63930 antibodies contribute to understanding plant immune receptor complex formation and dynamics?

At5g63930 antibodies could significantly advance our understanding of plant immune receptor dynamics through sophisticated spatiotemporal analysis techniques. Super-resolution microscopy combined with At5g63930-specific antibodies could reveal nanoscale organization of immune receptor complexes in the plasma membrane, potentially identifying previously unknown signaling microdomains. Time-resolved immunoprecipitation experiments followed by mass spectrometry could map the sequential assembly of signaling complexes following immune elicitation, building on recent findings that At5g63930's kinase domain can facilitate robust signal transduction . Cross-linking immunoprecipitation (CLIP) with At5g63930 antibodies could capture transient interactions that might be missed by conventional approaches. Additionally, antibodies could be employed in chaperone and quality control studies to understand how At5g63930 is correctly folded, transported, and maintained at the plasma membrane. Single-molecule tracking of labeled antibodies against the extracellular domain could provide insights into receptor mobility changes during immune activation. Finally, antibodies could help identify post-translational modifications beyond phosphorylation (such as ubiquitination or SUMOylation) that might regulate receptor function or turnover during sustained immune responses.

What role might At5g63930 play in cross-talk between different plant stress response pathways?

Recent findings suggest At5g63930 (PSYR3) may serve as an integrative node connecting multiple stress response networks. To investigate this potential role, researchers should design experiments examining At5g63930 expression, phosphorylation, and interaction partners under combined stress conditions. Transcriptional analysis has shown At5g63930 responds to both biotic and abiotic stressors, with potential roles in salinity responses indicated in dissertation work . Immunoprecipitation with At5g63930 antibodies followed by mass spectrometry under various stress conditions (pathogen, drought, salinity, cold) could identify condition-specific interaction partners. Functional studies in transgenic lines with modified At5g63930 expression should assess multiple stress response outputs simultaneously—measuring both immune markers (callose deposition, PR gene expression) and abiotic stress indicators (ROS production, ABA-responsive genes). The robust signal transduction capability of At5g63930's kinase domain in immune contexts suggests it may similarly transduce signals in other pathways. Phosphoproteomic analysis of plants under combined stresses could reveal At5g63930-dependent phosphorylation cascades that differ from single-stress responses. Ultimately, understanding At5g63930's role in stress cross-talk could provide valuable insights for developing crops with broad-spectrum resilience.